38 results on '"Tseng, Tai–Chung"'
Search Results
2. Serum RNase L levels in patients with chronic hepatitis B virus infection
3. Serial increase and high alpha‐fetoprotein levels predict the development of hepatocellular carcinoma in 6 months
4. The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan
5. Sofosbuvir/velpatasvir or glecaprevir/pibrentasvir for treating patients with hepatitis C virus reinfection following direct‐acting antiviral‐induced sustained virologic response
6. Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment
7. Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus‐coinfected patients receiving sofosbuvir‐based direct‐acting antivirals and antiretroviral therapy
8. Serum hepatitis B core‐related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load
9. Letter: elevated HBV DNA predicts poor survival in hepatocellular carcinoma after hepatic resection—authors' reply
10. Both hepatitis A and hepatitis D infections may be associated with more advanced liver disease in patients with chronic hepatitis B
11. A rare case of infiltrative hepatocellular carcinoma presented with neck mass
12. Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real‐world effectiveness and safety in Taiwan
13. Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
14. Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
15. Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
16. Make platelet count great again: Direct‐acting antiviral agent therapy in patients with chronic hepatitis C
17. NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging
18. Sofosbuvir‐based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
19. Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma
20. Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection
21. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B
22. Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan
23. Serum vitamin D level not correlated with hepatitis B virus replication in patients with chronic hepatitis B virus infection
24. Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues
25. Different risk factors between reflux symptoms and mucosal injury in gastroesophageal reflux disease
26. Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages
27. Hepatitis B virus infection and metabolic syndrome: Fact or fiction?
28. What can we learn from hepatitis B virus clinical cohorts?
29. Younger age and female sex predict a better therapeutic response in HBeAg-positive chronic hepatitis B patients to entecavir therapy
30. Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters
31. Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously
32. Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir
33. Male sex, hiatus hernia, and Helicobacter pylori infection associated with asymptomatic erosive esophagitis
34. Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk
35. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease
36. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients
37. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan
38. Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.